A New Type of Cancer Drug Shrinks Hard-to-Treat Tumors
New drugs called antibody-drug conjugates help patients with cancers that used to be beyond treatment
Source: scientificamerican.com
Shanu Modi News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Shanu Modi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Shanu Modi Today - Breaking & Trending Today
Dr Modi on Updated OS Data From the DESTINY-Breast04 Trial of T-DXd in HER2-Low Breast Cancer
Shanu Modi, MD, discusses updated survival data from the phase 3 DESTINY-Breast04 trial evaluating fam-trastuzumab deruxtecan-nxki in patients with HER2-low metastatic breast cancer.
Source: onclive.com
T-DXd Benefits Persist for HER2-Low Breast Cancer
Trastuzumab deruxtecan (T-DXd) provided sustained clinically meaningful improvement versus physician’s choice of treatment (TPC) for patients with advanced breast cancer and low HER2 expression.
Source: medscape.com
Trastuzumab Deruxtecan Sustains Survival Benefits in HER2-Low Metastatic Breast Cancer
Treatment with fam-trastuzumab deruxtecan-nxki led to sustained improvements in overall survival and progression-free survival vs physician’s choice of treatment in patients with previously treated HER2-low metastatic breast cancer, irrespective of hormone receptor status.
Source: onclive.com
Living With Metastatic Breast Cancer: A Mother's Story of Hope | Memorial Sloan Kettering Cancer Center
Learn how MSK's expertise in metastatic breast cancer helped a mother celebrate a long-awaited milestone with her family.
Source: mskcc.org